Details of the Drug-Related molecule(s) Interaction Atlas

US8598210, Table XV, 4 Drug Info

US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid; SCHEMBL1923034; CHEMBL3646215; BDBM107698; US8598210, Table XV, 4

Cross-matching ID

PubChem CID

24891734

TTD Drug ID

DM3XWMO

General Information of Drug (ID: DM3XWMO)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting HIF-prolyl hydroxylase 2 (HPH-2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
FG-4592	DM4XSQ2	Anaemia	3A90	Phase 3	[2]
US9422240, 1-298	DMH7DL5	N. A.	N. A.	Patented	[3]
US8598210, Table XV, 2	DMDK98P	N. A.	N. A.	Patented	[4]
US8536181, A41	DMF9LNO	N. A.	N. A.	Patented	[5]
US8598210, Table XV, 5	DMEU5ST	N. A.	N. A.	Patented	[6]
US8536181, C17	DMRTL63	N. A.	N. A.	Patented	[7]
US8921389, 210	DME1A80	N. A.	N. A.	Patented	[8]
US8536181, C35	DMAM51Z	N. A.	N. A.	Patented	[5]
US10100051, Compound 2	DMWESZ1	N. A.	N. A.	Patented	[9]
US8921389, 2	DMX7KDR	N. A.	N. A.	Patented	[8]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Prolyl hydroxylase inhibitors and methods of use. US8598210.
2	Crystalline forms of a prolyl hydroxylase inhibitor. US9115085.
3	Partially saturated nitrogen-containing heterocyclic compound. US9422240.
4	Prolyl hydroxylase inhibitors and methods of use. US9598370.
5	Prolyl hydroxylase inhibitors. US8536181.
6	Prolyl hydroxylase inhibitors and method of use. US8722895.
7	Methods for increasing the stabilization of hypoxia inducible factor-1 alpha. US8778412.
8	Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase. US9695170.
9	Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof. US10100051.